Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives as antiglioma agents

d-2-Hydroxyglutarate (d-2HG) is frequently found in human brain cancers. Approximately 50–80% of grade II glioma patients have a high level of d-2HG production, which can lead to cancer initiation. In this study, a series of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives were designed and synth...

Full description

Saved in:
Bibliographic Details
Published in:MedChemComm 2018-03, Vol.9 (3), p.471-476
Main Authors: Yi-Bin, Li, Hou, Wen, Lin, Hui, Ping-Hua, Sun, Lin, Jing, Wei-Min, Chen
Format: Article
Language:English
Subjects:
Brain
Brain cancer
Chemistry
Derivatives
Glioma cells
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:d-2-Hydroxyglutarate (d-2HG) is frequently found in human brain cancers. Approximately 50–80% of grade II glioma patients have a high level of d-2HG production, which can lead to cancer initiation. In this study, a series of novel 5-hydroxy-2-methyl-4H-pyran-4-one derivatives were designed and synthesized as antiglioma agents, and their related structure–activity relationships are discussed. Among these novel compounds, 4a exhibited promising anti-proliferative activity against glioma HT1080 cells and U87 cells with an IC50 of 1.43 μM and 4.6 μM, respectively. Further studies found that the most active compound (4a) shows an 86.3% inhibitory rate against the intracellular production of d-2HG at 1 μM, and dramatic inhibitory effects, even at 1 μM on the colony formation and migration of U87 and HT1080 cells.
ISSN:2040-2503
2040-2511
DOI:10.1039/c7md00551b